Found 5 matching trials
A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH) PHASE2 This is a single-arm and open-label study of ATG-008 for the Treatment of P...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial
A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) PHASE2 1\. This is a multi-center clinical study to evaluate dual mTORC1/2 inhibit...
Show More Location
Chongqing Cancer Hospital
Learn More & Join Trial
A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE1 This is an Open label, Phase โ
b Study of ATG-010 in Combination With ATG-00...
Show More Location
Chongqing Cancer Hospital
Learn More & Join Trial
ATG-008 Combined With Toripalimab in Advanced Solid Tumors PHASE1 This is an open-label, single-arm study with dose-escalation and expansion ...
Show More Location
Chongqing Cancer Hospital
Learn More & Join Trial
Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects PHASE2 This is an Asian multi-regional clinical trial (MRCT) in which ATG-008 will...
Show More Location
Oncology Hospital of Haerbin Medical University
Learn More & Join Trial